According to the Zhitong Finance App, Saisheng Pharmaceutical (300485.SZ) issued an announcement. The company's subsidiary, Beijing Saier Biopharmaceutical Co., Ltd. (hereinafter referred to as “Saierbio”), recently received a “Notice of Acceptance” from the State Drug Administration for the registration and marketing of drugs produced domestically.

According to the Zhitong Finance App, Saisheng Pharmaceutical (300485.SZ) issued an announcement. The company's subsidiary, Beijing Saier Biopharmaceutical Co., Ltd. (hereinafter referred to as “Saierbio”), recently received a “Notice of Acceptance” from the State Drug Administration for the registration and marketing of drugs produced domestically.